ICD-10-CM Billable Code

M1A.26

Drug-induced chronic gout, knee

Clinical Classification Guidelines

Medical Intelligence & Overview

Drug-induced chronic gout of the knee is a form of gout that develops over time due to the use of certain medications. Gout is a type of arthritis characterized by the accumulation of uric acid crystals within the joints, leading to inflammation and pain. When drugs trigger this condition, it tends to become a long-standing issue that affects the knee joint specifically. Recognizing this condition is important for managing symptoms and preventing joint damage.

Causes & Symptoms

Clinical Causes: Long-term use of medications that increase uric acid levels, such as diuretics, aspirin, and certain immunosuppressants Use of drugs that interfere with uric acid excretion or metabolism Combination of medications that collectively raise uric acid levels Pre-existing tendency for hyperuricemia (high uric acid levels) aggravated by certain drugs

Key Symptoms: Persistent pain, swelling, and redness in the knee Recurrent episodes of joint inflammation Limited range of motion in the affected knee Possible formation of tophi (urate crystal deposits) around the joint Discomfort that worsens during flare-ups and can become chronic

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical evaluation, medical history, and laboratory tests. Key steps include: - Physical examination revealing joint swelling, redness, and tenderness - Blood tests measuring serum uric acid levels - Synovial fluid analysis from the knee joint to identify uric acid crystals under microscopy - Imaging studies, such as X-rays or ultrasound, to detect joint damage and tophi - Review of medication history to identify drugs known to cause hyperuricemia Confirming drug-induced gout typically involves ruling out other causes of joint inflammation and establishing a temporal relationship between medication use and symptom onset.

Treatment Protocols: Management of drug-induced chronic gout in the knee focuses on alleviating symptoms, reducing uric acid levels, and addressing medication-related causes. Common approaches include: - Adjusting or discontinuing the causative medication in consultation with a healthcare provider - Use of anti-inflammatory medications like NSAIDs (nonsteroidal anti-inflammatory drugs) during flare-ups - Colchicine or corticosteroids to control inflammation - Long-term urate-lowering therapy, such as allopurinol or febuxostat, to prevent crystal formation - Lifestyle modifications, including dietary adjustments to reduce purine-rich foods and alcohol consumption - Ensuring adequate hydration to facilitate uric acid excretion It's important that treatment plans are individualized and overseen by a healthcare professional to effectively manage the condition and prevent disease progression.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M1A.26 a billable ICD-10 code?
Yes, M1A.26 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M1A.26?
Clinical documentation must specify the nature of Drug-induced chronic gout, knee and any associated comorbidities for accurate reporting.

Cite this Clinical Reference